Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Us Nuclear (UCLE) Return on Sales (2016 - 2025)

Historic Return on Sales for Us Nuclear (UCLE) over the last 10 years, with Q3 2025 value amounting to 0.25%.

  • Us Nuclear's Return on Sales rose 4300.0% to 0.25% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.83%, marking a year-over-year decrease of 500.0%. This contributed to the annual value of 0.79% for FY2024, which is 7400.0% up from last year.
  • As of Q3 2025, Us Nuclear's Return on Sales stood at 0.25%, which was up 4300.0% from 0.46% recorded in Q2 2025.
  • Us Nuclear's Return on Sales' 5-year high stood at 0.75% during Q4 2021, with a 5-year trough of 3.64% in Q2 2021.
  • For the 5-year period, Us Nuclear's Return on Sales averaged around 1.1%, with its median value being 1.03% (2023).
  • Over the last 5 years, Us Nuclear's Return on Sales had its largest YoY gain of 30700bps in 2021, and its largest YoY loss of -31600bps in 2021.
  • Over the past 5 years, Us Nuclear's Return on Sales (Quarter) stood at 0.75% in 2021, then tumbled by -189bps to 0.67% in 2022, then tumbled by -163bps to 1.77% in 2023, then fell by -27bps to 2.25% in 2024, then surged by 111bps to 0.25% in 2025.
  • Its last three reported values are 0.25% in Q3 2025, 0.46% for Q2 2025, and 1.18% during Q1 2025.